L'Oréal : Le T3 2024 devrait fortement décevoir malgré la confiance du management
>Reaction négative attendue - Neutre maintenu avec un OC abaissé à 401 €. Malgré la contre-performance du titre depuis fin juin, une réaction négative est attendue après la publication d’un T3 dont la croissance organique de 3.4% est décevante. Avec un T4 attendu sur une dynamique similaire, l’atterrissage de croissance organique sur 2024 devrait converger vers 5.5% (vs css VA de 6.9% pré-publication). L’abaissement des prévisions de croissance organique sur 2024 et ...L'Oreal acts as a holding company. Through its subsidiaries, Co. plays a strategic coordination role and scientific, industrial and marketing coordination role on a global basis. Co. develops, manufactures and commercializes products for Skin care, Hair care, Make-up, Perfumes, Toiletries and deodorants, and Oral cosmetics. Co. has three branches: Cosmetics, Body shop and Dermatology. Co.'s principal activities comprise four divisions: Professional Products, Consumer Products, L'Oreal Luxe and Active Cosmetics. The Body Shop branch offers various cosmetics and toiletry products. The Dermatology branch offers topical dermatology prescription, and corrective and aesthetic dermatology.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.